Wenyan Guo

Nov 25, 2024 | mdpi.com | Fei Wang |Jiawen Sun |Wenyan Guo |Yang Wu

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Jan 12, 2024 | pubs.rsc.org | Lin Chen |Wenyan Guo |Chun Mao |Jian Shen

Liver fibrosis: pathological features, clinical treatment and application of therapeutic nanoagents Liver fibrosis is a reversible damage-repair response, whose pathological features mainly include damage of hepatocytes, sinusoid capillarization, hepatic stellate cells (HSCs) activation, excessive accumulation of extracellular matrix (ECM) and inflammatory response.